Association between non-hypervascular hypointense nodules on Gadoxetic acid (cas 135326-11-3)-enhanced MRI and liver stiffness or hepatocellular carcinoma
-
Add time:08/18/2019 Source:sciencedirect.com
PurposeTo assess the association between non-hypervascular hypointense nodules (NHHNs) on gadoxetic acid-enhanced magnetic resonance imaging (MRI) and liver stiffness (LS) in patients with chronic liver disease, and analyzed their progression to overt hepatocellular carcinoma (HCC).
We also recommend Trading Suppliers and Manufacturers of Gadoxetic acid (cas 135326-11-3). Pls Click Website Link as below: cas 135326-11-3 suppliers
Prev:Quantitative analysis of Gadoxetic acid (cas 135326-11-3)-enhanced magnetic resonance imaging predicts histological grade of hepatocellular carcinoma
Next:Liver enhancement in healthy dogs after Gadoxetic acid (cas 135326-11-3) administration during dynamic contrast-enhanced magnetic resonance imaging) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Liver enhancement in healthy dogs after Gadoxetic acid (cas 135326-11-3) administration during dynamic contrast-enhanced magnetic resonance imaging08/19/2019
- Quantitative analysis of Gadoxetic acid (cas 135326-11-3)-enhanced magnetic resonance imaging predicts histological grade of hepatocellular carcinoma08/17/2019
- Gadoxetic acid (cas 135326-11-3)-enhanced high temporal-resolution hepatic arterial-phase imaging with view-sharing technique: Impact on the LI-RADS category08/16/2019
- T1 mapping on Gadoxetic acid (cas 135326-11-3)-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy08/15/2019
- Biliary tract enhancement in Gadoxetic acid (cas 135326-11-3)-enhanced MRI correlates with liver function biomarkers08/14/2019
- Avoiding Pitfalls in the Interpretation of Gadoxetic acid (cas 135326-11-3)–Enhanced Magnetic Resonance Imaging08/13/2019
- Gadoxetic acid (cas 135326-11-3)-enhanced dynamic magnetic resonance imaging using optimized integrated combination of compressed sensing and parallel imaging technique08/12/2019
- Relationship between transient severe motion of the liver in Gadoxetic acid (cas 135326-11-3) or iodinated contrast agent-enhanced imaging and arterial oxygen saturation and heart rate changes08/11/2019
- Gadoxetic acid (cas 135326-11-3)-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase08/10/2019
-
Health and Chemical more >


